AstraZeneca PLC is 5.0x more valuable than REGENERON PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $56.80 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | REGN | AZN |
|---|---|---|
| Market cap | $56.80 B | $286.27 B |
| US-listed rank | #292 | #45 |
| Revenue (latest FY) | $14.34B | - |
| Net income (latest FY) | $4.50B | - |
| Net margin | 31.4% | - |
| P/E (trailing FY) | 12.6 | - |
| SEC filings | 985 | 1,004 |
AstraZeneca PLC is 5.0x more valuable than REGENERON PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $56.80 B).
Full pages: REGENERON PHARMACEUTICALS, INC. and AstraZeneca PLC, or browse the full rankings.